United States Surgical Robots Market to Grow with a CAGR of 9.85% through 2030

Increasing Use of Surgical Robots in Treatment of Cancer and Rising Aging Population are expected to drive the United States Surgical Robots Market growth in the forecast period, 2026-2030

According to TechSci Research report, “United States Surgical Robots Market – By Region, Competition, Forecast & Opportunities, 2030F”, the United States Surgical Robots Market stood at USD 2.35 Billion in 2024 and is anticipated to grow with a CAGR of 9.85% in the forecast period.

There is a growing preference among patients and healthcare providers in the U.S. for minimally invasive surgical (MIS) procedures, primarily due to the clinical advantages of reduced tissue trauma, faster recovery times, lower infection risk, and shorter hospital stays. Surgical robotic systems are enhancing the feasibility and precision of complex MIS procedures, particularly in anatomically difficult cases. Their ability to deliver superior dexterity, visualization, and control is transforming surgical care delivery across various specialties. Hospitals are increasingly adopting robotic platforms as a strategic asset to differentiate themselves in a competitive market. Robotic-assisted surgery not only enhances surgical throughput and reduces complication rates but also strengthens hospital branding and patient retention. As MIS continues to become the standard of care, surgical robots are central to enabling better outcomes and improving patient satisfaction directly contributing to provider performance and financial sustainability.

The U.S. surgical robotics market is evolving rapidly, driven by breakthroughs in robotic hardware design, software intelligence, and the integration of complementary technologies such as AI, intraoperative imaging, and haptic feedback. Next-generation robotic systems are increasingly compact, modular, and cost-effective, broadening their deployment beyond academic medical centers to community hospitals and ambulatory surgical centers (ASCs). Advanced capabilities such as AI-driven surgical guidance, machine learning-based personalization, and real-time analytics are significantly enhancing procedural precision, reproducibility, and clinical decision-making. These innovations are accelerating surgeon adoption, improving patient safety, and reinforcing the return on investment for healthcare institutions. As product differentiation grows, innovation is becoming a key competitive lever in capturing market share and expanding clinical reach.

With mounting pressure to control healthcare costs and improve care quality, U.S. hospitals are prioritizing technologies that align with value-based reimbursement models and efficiency mandates. Surgical robots support these goals by enabling reduced complication rates, shorter inpatient stays, and faster patient recovery, which contribute to lower overall procedural costs. Leading health systems are leveraging the data and insights generated by robotic platforms to track surgical outcomes, benchmark performance, and refine clinical protocols. This integration of robotics into broader quality and operational improvement strategies enhances institutional readiness for value-based care. As payers and providers shift toward outcome-driven reimbursement models, investments in robotic-assisted surgery are increasingly seen not just as a clinical advantage, but as a strategic imperative for long-term cost-effectiveness and competitive positioning.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "United States Surgical Robots Market”

The United States Surgical Robots Market is segmented into application, end user, regional distribution, and company.

Based on its end user, the inpatient segment has emerged as the predominant market leader, Vietnam's healthcare sector, Inpatient facilities handle a substantial share of high-acuity, complex surgical procedures, including oncological, cardiovascular, thoracic, urological, and advanced gastrointestinal surgeries. These procedures often demand greater surgical precision, visualization, and dexterity, all of which are core advantages of robotic-assisted systems. Inpatient centers are more likely to adopt surgical robots as they frequently perform procedures where robotic systems can materially enhance outcomes. The ability to manage multi-specialty robotic programs (urology, gynecology, general surgery, etc.) allows hospitals to maximize equipment utilization and justify return on investment. Robotic surgery is increasingly embedded into hospital-based surgical training programs, reinforcing its role in standard care delivery within inpatient settings.

Inpatient hospitals typically operate with larger capital budgets and have more established supply chain and procurement systems, enabling them to invest in advanced surgical technologies like robotics. These institutions are well-positioned to absorb the high upfront costs of robotic platforms and the recurring costs of maintenance, software upgrades, and consumables. Comprehensive infrastructure, including dedicated robotic surgery suites, trained surgical teams, and post-operative care units, allows for full integration of robotic systems into clinical workflows. Hospitals often leverage robotic surgery capabilities to enhance institutional prestige, attract top surgeons, and improve rankings—especially in competitive urban markets.

Major companies operating in United States Surgical Robots Market are:

• Medtronic USA, Inc
• Intuitive Surgical, Inc.
• Stryker Corporation
• Johnson & Johnson
• Medrobotics Corporation
• TransEnterix, Inc.
• Zimmer Biomet Holdings, Inc.
• Think Surgical, Inc.
• Accuray Incorporated
• Globus Medical, Inc.

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The United States surgical robots market is poised for sustained expansion, driven by rapid technological advancements, rising demand for precision-based minimally invasive procedures, and growing institutional investments in robotic infrastructure. As robotic-assisted surgery transitions from a specialty innovation to a standard of care across multiple disciplines, market participants that prioritize clinical efficacy, cost-efficiency, and scalable solutions will be best positioned to lead. With strong adoption in inpatient settings and increasing penetration in outpatient and community healthcare facilities, the U.S. surgical robotics landscape is set to remain a global benchmark for innovation, clinical outcomes, and strategic growth.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“United States Surgical Robots Market, By Application (Orthopedics, Neurology, Urology, Gynecology, Others), By End User (Inpatient, Outpatient), By Region, Competition, Forecast & Opportunities, 2020-2030F”, has evaluated the future growth potential of United States Surgical Robots Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in United States Surgical Robots Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]